Parker Waichman LLP

Mercury Concerns Affect Medtronic’s Stent, Prompts Questions

We have been writing about a number of findings related to stents that were revealed at the Transcatheter Cardiovascular Therapeutics meeting that took place recently in Washington.  Because of the results of one of the studies, entitled Sort Out III, Medronic—a medical device maker—shares fell Thursday.  The study revealed that Medtronic’s new <“https://www.yourlawyer.com/topics/overview/drug_coated_stents”>drug-coated stent—the Endeavor—was […]

We have been writing about a number of findings related to stents that were revealed at the Transcatheter Cardiovascular Therapeutics meeting that took place recently in Washington.  Because of the results of one of the studies, entitled Sort Out III, Medronic—a medical device maker—shares fell Thursday.  The study revealed that Medtronic’s new <“https://www.yourlawyer.com/topics/overview/drug_coated_stents”>drug-coated stent—the Endeavor—was linked with increased heart attacks and blood clots versus a stent made by its rival, Johnson & Johnson.

Study results included over 2,000 patients and indicated that heart patients who received the Medtronic Endeavor, experienced more heart attacks and blood clots and also required repeat procedures more often than those who were implanted with Johnson & Johnson’ Cypher.  Medtronic spokesman, Joe McGrath, disagreed, “The data are also short-term,” McGrath said in a statement. “At nine months, it’s premature to draw any meaningful conclusions about a difference between Cypher and Endeavor.”  McGrath noted that, “Sort Out III at nine months has no bearing on what matters most to patients with coronary artery disease:  Long-term freedom from adverse events and long-term freedom from repeat procedures.”

In his statement, Dr. Campbell Rogers, chief scientific officer at Johnson & Johnson’s cardiovascular unit, the Cordis Corporation, said, “The breadth of clinical safety and efficacy data and the long-term patient outcomes associated with the Cypher stent are completely unmatched by the competition, and this gap continues to widen.”  Leerink Swann analyst, Rick Wise, said he felt the market had overreacted to the data.  Morgan Stanley analyst David Lewis, saw the downturn as a “modest negative” for Medtronic.  Medtronic shares were off about two percent, to close at $40.01.

Stents are tiny wire-mesh tubes used to prop open arteries after doctors clear them of blockages to restore blood flow and relieve chest pain

Two studies, one occurring at the annual Transcatheter Cardiovascular Therapeutics conference and another published separately, report that cardiac patients may fare better by receiving fewer artery-opening stents and that stents tend to be used arbitrarily.  Both studies focused on how to treat patients with clogged arteries, a condition known as ischemia, in which patients develop chest pains when blood flow to the heart’s muscle is blocked.

Following release of the study data and in an unprecedented move, eight medical companies are collaborating to initiate a $100 million study to understand how to best protect heart patients from rare but dangerous clots following heart stent implantation.  The study is intended to take four years and include 20,000 patients and will be looking at whether heart stent patients can safely be removed from aggressive blood-thinning treatment after one year, or if such patients would be better served by remaining on the medication for at least two and a-half years following implantation with a stent.  Today, guidelines mandate that those patients implanted with drug-coated stents remain on the medication for no less than one year; however, there is some concern about this course of treatment because clots can form in the devices well over a year after they are implanted, with potentially lethal consequences.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value I highly recommend Parker Waichman . Bonita Rollis was wonderful and very helpful and competent.
Arlene Savarese
2 years ago
5 Star Reviews 150
Good for the body of lawyers and all the staff, very good team, also congratulate Jorge Peniche for his excellent work, and his way of treating people, very good person.
Carlos Olmedo
5 years ago
5 Star Reviews 150
I'd like to say a few words about Joanne Stevens, NP. From the first phone call she answered ALL my questions and set me at ease with her knowledge and empathy. She calls me frequently and anytime I call her and get her VM, she returns my call within 24 hrs. without fail. I gave her 5 stars but she deserves 10. Thank you Joanne Stevens, just THANK YOU. Tina Schlobohm
Tina Schlobohm
4 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038